SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 111 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,613 | -24.9% | 10,368 | -26.6% | 0.00% | – |
| Q3 2022 | $98,000 | -65.1% | 14,134 | +65.9% | 0.00% | -100.0% |
| Q3 2021 | $281,000 | -8.5% | 8,519 | -19.7% | 0.00% | 0.0% |
| Q2 2021 | $307,000 | -45.2% | 10,606 | -4.1% | 0.00% | 0.0% |
| Q1 2021 | $560,000 | -16.5% | 11,061 | -20.0% | 0.00% | 0.0% |
| Q4 2020 | $671,000 | +205.0% | 13,825 | -43.8% | 0.00% | – |
| Q3 2019 | $220,000 | – | 24,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |